Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NEURIVE logo — A front runner for digital medical platform

NEURIVE

A front runner for digital medical platform

Founded 2018 Korea South Korea South 6 employees Seed Total: $1.20B Digital Health, Health and Wellness

General Information

Company Name NEURIVE
Founded Year 2018
Location Korea South Korea South +1
Employees 6
Industries Digital Health, Health and Wellness
Funding Stage Seed
Social

Get notified when NEURIVE moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NEURIVE

NEURIVE is a promising startup, positioning itself as a front runner for digital medical platforms. Established in 2018, the company focuses on developing cutting-edge technologies tailored to the specific needs of the medical sector. Its core expertise lies in the creation of electroceuticals and digital medical treatment devices. NEURIVE's primary area of interest is non-invasive vagus nerve stimulation technology, and the company's research and development efforts are directed towards the advancement of electroceuticals and other innovative technologies to revolutionize medical devices and medicine. Headquartered in South Korea, NEURIVE recently secured a significant milestone by raising a KRW1.00B Seed Round investment on 26 September 2021. The noteworthy participation of investors such as Magna Investment, SL Investment, and the Korea Entrepreneurship Foundation reflects the industry's confidence in the potential of NEURIVE's innovative concept and technology. With its strong focus on addressing the evolving needs of the medical field, NEURIVE's value proposition holds great promise for the future of digital medical platforms.

Taxonomy: Digital Medical Platforms, Electroceuticals, Vagus Nerve Stimulation, Non-invasive Medical Devices, Medical Device Innovation, Biomedical Research, Life Science Research, Medical Device Manufacturing, Software Development, Biotechnology Research, Healthcare Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 3
Investor Investor
•••• •••• 		26 Sep 2021
Non Equity Assistance •••••• 1 •••• •••• 01 Jun 2020
Seed Round •••••• - 01 May 2020

NEURIVE Alternatives & Competitors

NEURIVE vs
ATL Technology
ATL Technology United States

Improving Lives through Medical Device Innovation

Private Equity
481 employees
Manufacturing
NEURIVE vs
O'Brien Medical, LLC
O'Brien Medical, LLC United States

Introducing the ETF128, an innovative instrument tailored for the neurodiagnostic market.

Grant
3 employees
Medical Devices
NEURIVE vs
NSV Inc
NSV Inc United States

Reshaping Healthcare and Improving Patient Outcomes through Innovation

91 employees
AI, Health Care

FAQ About NEURIVE

A front runner for digital medical platform
NEURIVE was founded in 2018.
NEURIVE is headquartered in Korea South.
NEURIVE operates in the following industries: Digital Health, Health and Wellness.
NEURIVE has approximately 6 employees.
NEURIVE has completed 3 funding rounds, raising a total of $1.20B. The latest funding stage is Seed.
Top alternatives and competitors to NEURIVE include ATL Technology, O'Brien Medical, LLC, NSV Inc, STATECS, Angiotech Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NEURIVE and ATL Technology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NEURIVE and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy